Cargando…
c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays
Inflammatory breast carcinoma (IBC) is a rare but aggressive tumour associated with poor outcome owing to early metastases. Increased expression of c-Met protein correlates with reduced survival and high metastatic risk in human cancers including breast carcinomas and is targetable by specific drugs...
Autores principales: | Garcia, S, Dalès, J-P, Jacquemier, J, Charafe-Jauffret, E, Birnbaum, D, Andrac-Meyer, L, Lavaut, M-N, Allasia, C, Carpentier-Meunier, S, Bonnier, P, Charpin-Taranger, C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359990/ https://www.ncbi.nlm.nih.gov/pubmed/17242702 http://dx.doi.org/10.1038/sj.bjc.6603569 |
Ejemplares similares
-
Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905)
por: Dales, J P, et al.
Publicado: (2004) -
Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcome
por: Charpin, C, et al.
Publicado: (2009) -
c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease-free survival.
por: Charpin, C., et al.
Publicado: (1997) -
Automated and quantitative immunocytochemical assays of Bcl-2 protein in breast carcinomas.
por: Charpin, C., et al.
Publicado: (1997) -
VLA2 integrin expression in breast carcinomas evaluated by automated and quantitative immunohistochemistry.
por: Charpin, C., et al.
Publicado: (1998)